EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

SIMPATHY Study: Specific Antibody Response to Typhim Vi Polysaccharide as a Surrogate Marker of Infectious Risk in Secondary Immunodeficiency Associated with B Cell Cancer

Alejandro Peixoto-Rodriguez, Josefa Melero, Ana de Andrés, Eduardo López-Granados, Romina Dieli-Crimi, Adolfo Jiménez-Huete, Rodrigo Bailey-Maldonado, Carlos Jiménez, Elsa Mayol-Hornero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, María Guzmán-Fulgencio und 10 weitere

Journal of Clinical Immunology · 20.08.2026 · 46 (1)

DOI: 10.1007/s10875-026-02052-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Immunology, online erschienen am 20.08.2026. Verfasst von Alejandro Peixoto-Rodriguez und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos and IdISSC, Calle Profesor Martín Lagos S…. Hauptthemen laut MEDLINE: Polysaccharides, Bacterial, Antibodies, Bacterial, Typhoid-Paratyphoid Vaccines, Immunologic Deficiency Syndromes. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grifols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent and severe infections represent a major cause of morbidity and mortality of secondary immunodeficiency (SID) associated with B-cell lymphoproliferative syndromes (B-CLPD). Nevertheless, immunological evaluation and prophylactic interventions are often delayed until infectious complications occur. Early vaccination is therefore relevant not only because it provides protection during the initial phases of B-CLPD, but also because it enables the identification of patients at higher risk of infection. In this context, assessment of antigen-specific humoral response has been proposed as a useful biomarker for identifying patients with greater clinical vulnerability. We conducted SIMPATHY (Secondary Immunodeficiency Multicentric study on the Antibody Production to Typhi vaccine), a multicentre, retrospective, observational study including 128 individuals with B-CLPD, classified according to the presence or absence of severe and/or recurrent infections, as well as healthy controls. Specific IgG antibody responses to Streptococcus pneumoniae (13-valent conjugate, Prevenar), Salmonella typhi (Typhim Vi), and tetanus toxoid vaccines were assessed at baseline and 4-weeks after vaccination. Among 128 individuals analysed, patients with B-CLPD showed significant immunological and clinical differences compared to healthy controls, particularly in vaccine-specific antibody responses and lymphocyte subsets. B-CLPD patients with recurrent or severe infections exhibited markedly reduced pre-vaccination anti-pneumococcal ( p = 0.03) and post-vaccination anti-pneumococcal ( p = 0.001) and anti- Salmonella typhi Vi titers ( p = 0.1), highlighting impaired vaccine-specific antibody responses as potential predictors of infection risk. An immunological classification identified two subgroups within B-CLPD, predominant antibody defect and combined immune defect, with a trend toward higher respiratory infection rates in the latter, suggesting broader immune dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polysaccharides, BacterialAntibodies, BacterialTyphoid-Paratyphoid VaccinesImmunologic Deficiency SyndromesLymphoma, B-CellHumansFemaleMaleBiomarkersAntibody FormationRetrospective StudiesAdultImmunoglobulin GAdolescentVaccinationMiddle AgedYoung Adult

Stichwörter der Autor:innen

B-cell lymphoproliferative disorderPolysaccharide vaccinesSecondary immunodeficiencyTyphim ViVaccine-specific biomarkers

Substanzen

Polysaccharides, BacterialAntibodies, BacterialBiomarkersTyphoid-Paratyphoid VaccinesVi polysaccharide vaccine, typhoidImmunoglobulin G

Autor:innen und Institutionen

  • Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Clínico San Carlos and IdISSC, Calle Profesor Martín Lagos SN, Madrid, 28040, Spain.
  • Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.
  • Basic Medical Sciences, Physiology. Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28660, Spain.
  • Department of Immunology, Infanta Cristina Hospital, Badajoz, Spain.
  • Department of Immunology, Ramón y Cajal Hospital, Madrid, Spain.
  • Department of Immunology, La Paz University Hospital, Madrid, Spain.

Förderung

  • Grifols

Zitieren

APA

Peixoto-Rodriguez, A., Melero, J., de Andrés, A., López-Granados, E., Dieli-Crimi, R., Jiménez-Huete, A., Bailey-Maldonado, R., Jiménez, C., Mayol-Hornero, E., Cuesta-Mínguez, C., Rodríguez-Sanz, A., Guzmán-Fulgencio, M., Ochoa-Grullón, J., Peña-Cortijo, A., Polo Zarzuela, M., Íñigo, B., Mateo Morales, M., Anguita-Mandly, E., Fernández-Arquero, M., …, & Sánchez-Ramón, S. (2026). SIMPATHY Study: Specific Antibody Response to Typhim Vi Polysaccharide as a Surrogate Marker of Infectious Risk in Secondary Immunodeficiency Associated with B Cell Cancer. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02052-8

Vancouver

Peixoto-Rodriguez A, Melero J, de Andrés A, López-Granados E, Dieli-Crimi R, Jiménez-Huete A, et al. SIMPATHY Study: Specific Antibody Response to Typhim Vi Polysaccharide as a Surrogate Marker of Infectious Risk in Secondary Immunodeficiency Associated with B Cell Cancer. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02052-8

BibTeX
@article{PeixotoRodriguez2026,
  author = {Peixoto-Rodriguez, Alejandro and Melero, Josefa and de Andrés, Ana and López-Granados, Eduardo and Dieli-Crimi, Romina and Jiménez-Huete, Adolfo and Bailey-Maldonado, Rodrigo and Jiménez, Carlos and Mayol-Hornero, Elsa and Cuesta-Mínguez, Cristina and Rodríguez-Sanz, Aránzazu and Guzmán-Fulgencio, María and Ochoa-Grullón, Juliana and Peña-Cortijo, Ascensión and Polo Zarzuela, Marta and Íñigo, Belén and Mateo Morales, Marta and Anguita-Mandly, Eduardo and Fernández-Arquero, Miguel and Benavente-Cuesta, Celina and Lavandera-Díaz, José Luis and Sánchez-Ramón, Silvia},
  title = {SIMPATHY Study: Specific Antibody Response to Typhim Vi Polysaccharide as a Surrogate Marker of Infectious Risk in Secondary Immunodeficiency Associated with B Cell Cancer},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10875-026-02052-8}
}
Kostenlos starten →